Survey on Practice and Comparison With Best Evidence in Surgical Site Infection Prevention in Colorectal Surgery (PREVISQCOR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03883399|
Recruitment Status : Recruiting
First Posted : March 20, 2019
Last Update Posted : March 20, 2019
|Condition or disease||Intervention/treatment|
|Colorectal Surgery Surgical Site Infection||Other: Survey|
A web-based survey (SurveyMonkey©; https://es.surveymonkey.com/r/FBVR59C) to the members of the Colorectal Chapter of the Spanish Association of Surgeons (AEC) and the Spanish Association of Coloproctology (AECP). A link to the web page containing the survey is disseminated via email, newsletter and Twitter.
A board from the Surgical Infection Section did a review of evidence and previous guidelines to be used in the evaluation of the results. The most recent clinical practice guidelines have been analysed. Furthermore, an extensive review of specific measures for colorectal surgery has been published and used for evaluation. According to the review, the preventive measures analysed in the survey have been distributed into two groups: high or low level of evidence.
The survey aim to assess knowledge, beliefs, and practices of attending colorectal surgeons on preventative measures including mechanical bowel preparation (MBP), oral antibiotic prophylaxis and the use of drains. Furthermore, the questions address the level of accordance between their beliefs and the protocols or the usual practice of their units. The agreement rate between the beliefs and usual practice of all respondents will be calculated on a scale from 0 to 100. For discussion, the responses on the implementation of major surgical site infection (SSI) prevention measures will be compared with the recommendations of the expert group. Other questions are related to the types of complications that surgeons believe are prevented by the use of oral antibiotic prophylaxis or MBP, reasons for not using either of them, type of oral and systemic antibiotics and cathartics used, and strategies already in place or that should be implemented to reduce SSI rates at respondents' hospitals.
The results will be expressed in percentages on the total answers obtained. Responses will be entered into a computerized database that will be analysed using the SPSS program (v.10.0, Chicago, IL, USA). The results will be analysed using the chi-square test with statistical significance defined as p <0.05.
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||Awareness of Practice and Comparison With Best Evidence in Surgical Site Infection Prevention in Colorectal Surgery|
|Actual Study Start Date :||November 1, 2018|
|Estimated Primary Completion Date :||May 30, 2019|
|Estimated Study Completion Date :||June 30, 2019|
Survey among Spanish colorectal surgeons
Survey among colorectal surgeons
- Awareness of practice - Percentage of responders who use each preventive measures for surgical site infection [ Time Frame: 2019 ]Percentage of responders who use each preventive measures for surgical site infection (including mechanical bowel preparation and oral antibiotic prophylaxis), compared to their beliefs and knowledge of scientific evidence.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03883399
|Contact: Josep M Badiaemail@example.com|
|Fundació Privada Hospital Asil de Granollers||Recruiting|
|Granollers, Barcelona, Spain, 08402|
|Contact: Josep Maria Badia, PhD (+34) 938 425 000 ext 2571 firstname.lastname@example.org|
|Contact: Gemma Molist, PhD (+34) 938 425 000 ext 2973 email@example.com|
|Principal Investigator: Josep Maria Badia, PhD|
|Sub-Investigator: Felipe Ojeda, PhD|
|Principal Investigator:||Josep M Badia||Universitat Internacional de Catalunya|